2b SharesFY 26 Revenue expected $100mEV/Revenue Multiple of x10$1bil valuation over shares on issueStill gives us a conservative 50cent share price in 12 monthsFrom CMP the upside is more than 100%Lot went wrong but its still selling and a scaling derma product. Give it 12 months to get a good uptake in the market.
In for the long haul.
I get it plenty have lost money. Im still down but not far off. Could've been worse.
Held this long and still my numbers and valuation is unchanged.
Conservative by nature and my valuation and estimates as rough as they were, were not ridiculously extend like others here.
This is not for newbies or the feint hearted, the long runway, aggressive forecasts, and product execution requirements mean there's meaningful downside if anything falters yet again, that's what we saw. Coupled with short action, panic selling
it was just the whole recipe needed for a massive drop.
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Provides Sofdra Launch Update
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
3.33%
!
14.5¢

Ann: Botanix Provides Sofdra Launch Update, page-461
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $284.3M |
Open | High | Low | Value | Volume |
15.0¢ | 15.3¢ | 14.0¢ | $2.762M | 18.84M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 858705 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 1328637 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 634170 | 0.145 |
114 | 4741779 | 0.140 |
60 | 1685018 | 0.135 |
65 | 10247538 | 0.130 |
29 | 743654 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 1325137 | 13 |
0.155 | 2261525 | 14 |
0.160 | 861660 | 15 |
0.165 | 491555 | 13 |
0.170 | 1352734 | 31 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online